David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.15% |
| 2 | Financials | 9.51% |
| 3 | Healthcare | 7.52% |
| 4 | Consumer Discretionary | 6.79% |
| 5 | Communication Services | 5.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
CALL
CrowdStrike
CRWD
$195B
| $72.6M | 0.09% |
1,762,800
-88,400
| -5% | -$4.04M |
|
227
PNC Financial Services
PNC
$97B
| $71.8M | 0.09% |
480,478
-452,537
| -49% | -$73.3M |
|
228
Marvell Technology
MRVL
$213B
| $71.7M | 0.09% |
1,670,074
+369,935
| +28% | +$18.3M |
|
|
KRTX
229
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $71.6M | 0.09% |
318,120
+312,660
| +5,726% | +$63.3M |
|
230
PUT
Devon Energy
DVN
$54B
| $71.4M | 0.09% |
1,187,400
+316,300
| +36% | +$19.7M |
|
231
Microchip Technology
MCHP
$41.3B
| $71.4M | 0.09% |
1,169,727
+93,031
| +9% | +$6.11M |
|
232
Nutrien
NTR
$35.9B
| $71.2M | 0.09% |
854,430
-490,177
| -36% | -$42.2M |
|
233
PUT
Ford
F
$57.5B
| $71M | 0.08% |
6,342,900
-1,451,500
| -19% | -$20.3M |
|
234
PUT
Nike
NKE
$60.5B
| $71M | 0.08% |
853,900
-465,500
| -35% | -$50.1M |
|
235
Sysco
SYY
$40.2B
| $70.9M | 0.08% |
1,002,900
+309,688
| +45% | +$25.8M |
|
236
Capital One
COF
$134B
| $70.9M | 0.08% |
769,343
+36,477
| +5% | +$3.88M |
|
237
Boston Scientific
BSX
$73B
| $70.6M | 0.08% |
1,822,012
-854,832
| -32% | -$34.3M |
|
238
Carrier Global
CARR
$49.8B
| $70.5M | 0.08% |
1,983,563
-1,597,264
| -45% | -$62.9M |
|
239
CALL
Snowflake
SNOW
$115B
| $70.5M | 0.08% |
414,900
+291,900
| +237% | +$48.3M |
|
|
SBNY
240
DELISTED
Signature Bank
SBNY
| $70.2M | 0.08% |
465,010
+253,854
| +120% | +$46.1M |
|
241
Sarepta Therapeutics
SRPT
$1.98B
| $70M | 0.08% |
632,861
+371,378
| +142% | +$37.4M |
|
242
BJs Wholesale Club
BJ
$12.3B
| $69.9M | 0.08% |
960,496
+177,556
| +23% | +$12.7M |
|
243
Elanco Animal Health
ELAN
$12B
| $69.8M | 0.08% |
5,622,087
+3,152,960
| +128% | +$55.1M |
|
244
Dick's Sporting Goods
DKS
$16.4B
| $69.7M | 0.08% |
666,240
+378,805
| +132% | +$38.5M |
|
245
Becton Dickinson
BDX
$52.3B
| $69.7M | 0.08% |
312,571
-39,083
| -11% | -$9.73M |
|
246
Natera
NTRA
$47.9B
| $69.3M | 0.08% |
1,582,059
-190,008
| -11% | -$9.04M |
|
247
ON Semiconductor
ON
$28.9B
| $68.6M | 0.08% |
1,100,121
+425,653
| +63% | +$27.4M |
|
248
Textron
TXT
$14.3B
| $68.6M | 0.08% |
1,176,624
-166,223
| -12% | -$10.5M |
|
249
CALL
Procter & Gamble
PG
$336B
| $68M | 0.08% |
538,900
-32,900
| -6% | -$4.67M |
|
250
CALL
Albemarle
ALB
$16.9B
| $67.4M | 0.08% |
255,000
+117,400
| +85% | +$29.9M |
|
Similar funds
David Shaw's Q3 2022 Portfolio in Review
As of Q3 2022, David Shaw held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
David Shaw withdrew a net $3.66B in Q3 2022, closing 678 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, David Shaw opened a new position in Prologis worth $66.1M.
- David Shaw's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- David Shaw added most to Visa in Q3 2022, an estimated $365M increase.
- David Shaw's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- David Shaw fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- David Shaw's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- David Shaw opened 545 new positions and closed 678 in Q3 2022.
- David Shaw's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.